GCICanaccord Genuity lowers target price on Nexteq
Analysts at Canaccord Genuity lowered their target price on B2B technology group from 300.0p to 200.0p on Wednesday despite "strong margins and cash", noting that destocking persisted.
Canaccord said revenue for H124 was expected to be $48.2m, down 15% year-on-year, reflecting soft demand across both its Quixant and Densitron offerings as a result of persistent destocking, in line with wider industry trends.
The Canadian bank also said the impact has been amplified by some larger customers deciding to delay planned product launches and instead sweat assets for longer given a challenging macro backdrop.
"We have updated our model to reflect the new guidance. This sees our FY24E adjusted pre-tax profit reduce by 36% to $9.6m. We now see net cash 7% better at $38.0m. For FY25, the timing of planned customer spending remains uncertain at present, but we expect strong margins and a continued focus on cost management to at least maintain profit levels. We reduce FY25E adjusted PBT by 42% to $9.7m as a result," said Canaccord, which has a 'buy' rating on the stock.
"On our revised estimates, Nexteq trades on a P/E of 13.9x for 2024E falling to 13.7x for 2025E. P/E ex cash is 8.6x/8.0x respectively with net cash representing ~38% of current market capitalisation. That looks too cheap for us given the strength of gross margins and underlying cash generation, while absolute profit levels are likely to rebuild quickly, in our view, as cyclical destocking trends ease."
Reporting by Iain Gilbert at Sharecast.com
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.